Biotech Investor Adds Million as Krystal Biotech Revenue Rises
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Fundamental analysis is key to maximizing stock returns. By evaluating financial health, you can make informed investment choices that lead to higher profits.
22,179 articlesA major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
The quantum race isn’t just about flashy qubit players. The real upside sits in the infrastructure that makes quantum...
AI-driven demand and easing supply bottlenecks push chipmakers into the spotlight. Here’s a timely look at the best s...
NVIDIA led the AI chip boom, but growing competition and supply forces may erode its edge. This guide breaks down the...
NVDL plunged sharply in early 2025 as daily rebalancing magnified losses, even as NVDA fell less. Analysts warn this ...
A seemingly small line in Nvidia's latest earnings release hints at a larger shift toward edge computing. For investo...
The latest pullback in software-as-a-service stocks may feel painful, but it also creates patient-buying opportunitie...
ASML Holdings rode a broad wave of positive signals in June, even without a fresh earnings release. This article brea...
Mega-cap tech now drives most S&P 500 gains, leaving the rest of the market with thinner support. Here’s what investo...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
As hyperscalers pour money into AI and data centers, a select pair of stocks stands out for long-term holders. Vertiv...